Related Experiment Videos
Adrenergic shock--an overlooked clinical entity?
Branislav Schifferdecker1, Dhatri Kodali, Eva Hausner
1Division of Cardiovascular Medicine, St. Vincent Hospital at Worcester Medical Center, University of Massachusetts Medical School, Worcester, Massachusetts, USA. bschifferdecker@yahoo.com
Cardiology in Review
|February 12, 2005
Summary
Pheochromocytoma can cause recurrent shock and cardiomyopathy, even in healthy patients. Early diagnosis and treatment are crucial for managing this rare condition.
Area of Science:
- Endocrinology
- Cardiology
- Oncology
Background:
- Pheochromocytoma, a rare neuroendocrine tumor, can secrete catecholamines, leading to severe cardiovascular complications.
- Shock and cardiomyopathy are uncommon but critical manifestations of pheochromocytoma, posing diagnostic challenges.
Observation:
- A previously healthy, normotensive patient presented with recurrent shock attributed to an undiagnosed pheochromocytoma.
- The patient experienced severe hemodynamic instability and cardiac dysfunction consistent with catecholamine-induced cardiomyopathy.
Findings:
- This case highlights the potential for pheochromocytoma to induce life-threatening shock and cardiomyopathy.
- Review of literature reveals diverse clinical presentations of pheochromocytoma, emphasizing the need for high index of suspicion.
Implications:
- Prompt diagnostic evaluation, including biochemical and imaging studies, is essential for identifying pheochromocytoma in patients with unexplained shock.
- Effective management involves surgical resection of the tumor and medical therapy to control catecholamine excess and cardiovascular dysfunction.